©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2006; 12(2): 204-213
Published online Jan 14, 2006. doi: 10.3748/wjg.v12.i2.204
Published online Jan 14, 2006. doi: 10.3748/wjg.v12.i2.204
Table 1 Single agent activity in advanced gastric cancer
| Agents | Response rate (%) |
| Mitomycin C | 30 |
| Doxorubicin | 17 |
| Epirubicin | 19 |
| Cisplatin | 19 |
| BCNU | 18 |
| 5-Fluorouracil | 21 |
| Etoposide (oral) | 21 |
| Hydroxurea | 19 |
| UFT | 27 |
| Capecitabina | 19 |
| S-1 | 45 |
| Paclitaxel | 17-23 |
| Docetaxel | 17-29 |
| CPT-11 | 18 |
- Citation: Sastre J, García-Saenz JA, Díaz-Rubio E. Chemotherapy for gastric cancer. World J Gastroenterol 2006; 12(2): 204-213
- URL: https://www.wjgnet.com/1007-9327/full/v12/i2/204.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i2.204